Aerosol Delivery and COPD Readmissions
Aerosol Delivery Devices for Obstructive Lung Diseases
Chronic obstructive pulmonary disease - The Lancet
Aerosol Delivery & COPD Readmissions: Proper aerosol therapy adherence for COPD patients can help prevent and reduce 30-day readmissions rates for hospitals, but compliance can rely on finding the right technology
Frontiers The impact of metabolic overweight/obesity phenotypes on unplanned readmission risk in patients with COPD: a retrospective cohort study
Two-way remote monitoring allows effective and realistic provision of home-NIV to COPD patients with persistent hypercapnia
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective - The Lancet Respiratory Medicine
Aerosol Plumes of Inhalers Used in COPD
Aerosol Delivery & COPD Readmissions: Proper aerosol therapy adherence for COPD patients can help prevent and reduce 30-day readmissions rates for hospitals, but compliance can rely on finding the right technology
Nebulized LABA Therapy for COPD
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives - Haarst - 2019 - Clinical Pharmacology & Therapeutics - Wiley Online Library
Peak Inspiratory Flow Rate in COPD: Clinical Trial Analyses
Aerosol Delivery Devices for Obstructive Lung Diseases
Frontiers Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
